Related Experiment Video
Updated: Jul 15, 2026
09:13
Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017
[218 tooth extraction in patients taking platelet aggregation inhibitors]
J Garnier1, F Truchot, J Quero
1Département d'odontologie et de chirurgie buccale, faculté d'odontologie, université de Rennes-I, CHU de Rennes, 2, avenue du Professeur-Léon-Bernard, bâtiment 15, 35043 Rennes cedex, France.
Revue De Stomatologie Et De Chirurgie Maxillo-Faciale
|April 28, 2007
Summary
Tooth extraction is safe for patients on antiplatelet agents. Applying local hemostasis protocols effectively manages bleeding risk, minimizing complications during dental procedures.
Area of Science:
- Oral surgery
- Cardiology
- Pharmacology
Context:
- Patients on antiplatelet agents require careful management for dental procedures.
- Antiplatelet therapy is crucial for preventing thrombotic diseases.
Purpose:
- To evaluate the safety and hemostatic control of tooth extraction in patients undergoing antiplatelet therapy.
- To determine the incidence of bleeding complications in this patient group.
Summary:
- A retrospective analysis of 52 patients (218 extractions) on antiplatelet agents was conducted.
- A local hemostasis protocol (filling, suture, compression) was applied to all extractions.
- A low rate of hemorrhagic complications (1.3% sockets, 1.9% patients) was observed, with bleeding effectively managed by local hemostasis.
Impact:
- Demonstrates that tooth extractions can be safely performed in patients on antiplatelet therapy.
- Highlights the efficacy of local hemostasis in controlling post-extraction bleeding.
- Supports the continuation of antiplatelet therapy during necessary dental extractions.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:26Tonsillitis II: Management
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.